Evidence map›Paper›PMID 40449999›Full record

ArticleNature communications2025

Precision multiplexed base editing in human cells using Cas12a-derived base editors.

Anabel Y Schweitzer, Etowah W Adams, Michael T A Nguyen, Monkol Lek, Farren J Isaacs

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Molecular mechanisms and biotechnology applications of CRISPR-Cas12a.Nature reviews. Molecular cell biology · 2026
    Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anabel Y SchweitzerDepartment of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, CT, USA.ORCID http://orcid.org/0009-0006-8838-218X
Etowah W AdamsDepartment of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, CT, USA.
Michael T A NguyenDepartment of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, CT, USA.ORCID http://orcid.org/0000-0003-3857-0327
Monkol LekDepartment of Genetics, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0003-1227-6293
Farren J IsaacsDepartment of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, CT, USA. farren.isaacs@yale.edu.ORCID http://orcid.org/0000-0001-8615-8236

Funding

Revealing substrates and phosphoproteome level function of human STE20 kinasesR01GM117230 · NIGMS · YALE UNIVERSITY · PI ISAACS, FARREN J., RINEHART, JESSE · 2015 to 2024
$3.2M
Carlsbergfondet (Carlsberg Foundation) CF22-1046NIGMS NIH HHS R01 GM117230U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) GM117230
6 · The paper itself

Abstract

Base editors enable the direct conversion of target nucleotides without introducing DNA double strand breaks, making them a powerful tool for creating point mutations in a human genome. However, current Cas9-derived base editing technologies have limited ability to simultaneously edit multiple loci with base-pair level precision, hindering the generation of polygenic phenotypes. Here, we test the ability of six Cas12a-derived base editing systems to process multiple gRNAs from a single transcript. We identify base editor variants capable of multiplexed base editing and improve the design of the respective gRNA array expression cassette, enabling multiplexed editing of 15 target sites in multiple human cell lines, increasing state-of-the-art in multiplexing by three-fold in the field of mammalian genome engineering. To reduce bystander mutations, we also develop a Cas12a gRNA engineering approach that directs editing outcomes towards a single base-pair conversion. We combine these advances to demonstrate that both strategies can be combined to drive multiplex base editing with greater precision and reduced bystander mutation rates. Overcoming these key obstacles of mammalian genome engineering technologies will be critical for their use in studying single nucleotide variant-associated diseases and engineering synthetic mammalian genomes.

Indexed as

CRISPR-Associated ProteinsCRISPR-Cas SystemsEndodeoxyribonucleasesGene EditingBacterial ProteinsCell LineGenome, HumanHEK293 CellsHumansRNA, Guide, CRISPR-Cas SystemsBacterial ProteinsCas12a proteinCRISPR-Associated ProteinsEndodeoxyribonucleasesRNA, Guide, CRISPR-Cas Systems

Identifiers

PMID40449999
PMCPMC12126522

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.